Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-28T01:09:58.314Z Has data issue: false hasContentIssue false
  • English
  • Français

Thyrotoxic Periodic Paralysis, β2-ADrenergic Bronchodilator, and Insulin—An Interesting Interplay

Published online by Cambridge University Press:  04 March 2015

Subramanian Senthilkumaran ,
Narendra Nath Jena ,
Srinivasan Jayaraman  and
Ponniah Thirumalaikolundusubramanian
Subramanian Senthilkumaran
Affiliation:
Department of Emergency and Critical Care, Sri Gokulam Hospitals and Research Institute, Salem, Tamil Nadu, India
Narendra Nath Jena
Affiliation:
Department of Emergency Medicine, Meenakshi Mission Hospital & Research Centre, Madurai, India
Srinivasan Jayaraman
Affiliation:
Department of Emergency Medicine, Hamad General Hospital, Doha, Qatar
Ponniah Thirumalaikolundusubramanian
Affiliation:
Department of Internal Medicine, Chennai Medical College Hospital and Research Center, Irungalur, Trichy, Tamil Nadu, India

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters • Correspondance
Information
Canadian Journal of Emergency Medicine , Volume 16 , Issue 5 , September 2014 , pp. 343
Copyright
Copyright © Canadian Association of Emergency Physicians 2014

References

1. Yeh, FC, Chiang, WF, Wang, CC, Lin, SH. Thyrotoxic periodic paralysis triggered by ²2-adrenergic bronchodilators. CJEM 2013;15:1–5.Google Scholar
2. Lee, KO, Taylor, EA, Oh, VM, et al. yperinsulinaemia in thyrotoxic hypokalaemic periodic paralysis. Lancet 1991;337:1063–4, doi:10.1016/0140-6736(91)91710-C.Google Scholar
3. Haffner, CA, Kendall, MJ. Metabolic effects of ²2-agonists. J Clin Pharm Ther 1992;17:155–64, doi:10.1111/j.1365-2710.1992.tb01285.x.CrossRefGoogle Scholar
4. Chang, CC, Cheng, CJ, Sung, CC, et al. A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants. Eur J Endocrinol 2013;169:529–36, doi:10.1530/EJE-13-0381.Google Scholar
5. Thomas, D, Gill, B, Brown, P, Stubbs, W. Salbutamol-induced diabetic ketoacidosis. Br Med J 1977;2:438, doi:10.1136/bmj.2.6084.438.Google Scholar